AI assistant
RESMED INC — Director's Dealing 2015
Nov 13, 2015
30071_dirs_2015-11-13_3df77aca-7442-4774-9e42-fcdca630f474.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-11-11
Reporting Person: Hollingshead James (President, Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-11 | ResMed Common Stock | F | 3758 | $58.37 | Disposed | 64060.385 | Direct |
| 2015-11-11 | ResMed Common Stock | F | 2918 | $58.37 | Acquired | 61142.385 | Direct |
| 2015-11-11 | ResMed Common Stock | F | 2088 | $58.37 | Disposed | 59054.385 | Direct |
| 2015-11-11 | ResMed Common Stock | F | 2485 | $58.37 | Disposed | 56569.385 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/16/2011.
F2: Includes 138.789 shares of stock purchased on October 30, 2015, through ResMed's Employee Stock Purchase Plan.
F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/15/2012.
F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013.
F5: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2014.